GynecologyNews.net

Gynecology Xagena

Search results for "Endometriosis"

The FDA ( Food and Drug Administration ) approved Depo-subQ Provera 104 ( Medroxyprogesterone ) for the management of pain associated with endometriosis. The drug is the first new treatment option ...


Researchers at Cedars-Sinai Medical Center and the University of California at Los Angeles conducted a study regarding molecular mechanism involved in the human implantation process, specifically targ ...


The live birth rate per woman was significantly higher in women with endometriosis who received gonadotrophin releasing hormone ( GnRH ) agonist for three to six months before commencing in vitro fert ...


The results of a study have shown a possible association between endometriosis and periodontal disease.Endometriosis occurs when the tissue lining the uterus, the endometrium, begins to grow and shed ...


The TGA's Urogynaecological Devices Working Group ( UDWG ) has provided advice following a safety communication published by the US Food and Drug Administration ( FDA ) which advised against the use o ...


The objective of a study was to determine the risk of ovarian cancer, including malignant and borderline ovarian tumors, in women who have been exposed to assisted reproductive therapy ( ART ). Rec ...


Results from the second of two replicate pivotal phase 3 clinical trials evaluating the efficacy and safety of Elagolix in premenopausal women who suffer pain from endometriosis were presented. Tria ...


A study has estimated the prevalence of surgically confirmed endometriosis in women undergoing laparoscopic or abdominal hysterectomy, including those with and without preoperative indications of chro ...


Although there are various hormone therapies, including gonadotropin-releasing hormone agonist, Danazol, Levonorgestrel-releasing intrauterine system, Dienogest, and low-dose estrogen progestin, no co ...